BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25574741)

  • 1. Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.
    Ruiz C; Li J; Luttgen MS; Kolatkar A; Kendall JT; Flores E; Topp Z; Samlowski WE; McClay E; Bethel K; Ferrone S; Hicks J; Kuhn P
    Phys Biol; 2015 Jan; 12(1):016008. PubMed ID: 25574741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating melanoma cells and survival in metastatic melanoma.
    Rao C; Bui T; Connelly M; Doyle G; Karydis I; Middleton MR; Clack G; Malone M; Coumans FA; Terstappen LW
    Int J Oncol; 2011 Mar; 38(3):755-60. PubMed ID: 21206975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
    Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
    Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
    Joshi P; Jacobs B; Derakhshan A; Moore LR; Elson P; Triozzi PL; Borden E; Zborowski M
    Oncotarget; 2014 May; 5(9):2450-61. PubMed ID: 24811334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
    Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
    J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
    Rapanotti MC; Viguria TMS; Spallone G; Terrinoni A; Rossi P; Costanza G; Campione E; Lombardo P; Pathirannehalage CD; Orlandi A; Bernardini S; Bianchi L
    Cancer Treat Res Commun; 2020; 25():100262. PubMed ID: 33338742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells.
    Freeman JB; Gray ES; Millward M; Pearce R; Ziman M
    J Transl Med; 2012 Sep; 10():192. PubMed ID: 22978632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.
    Ulmer A; Beutel J; Süsskind D; Hilgers RD; Ziemssen F; Lüke M; Röcken M; Rohrbach M; Fierlbeck G; Bartz-Schmidt KU; Grisanti S
    Clin Cancer Res; 2008 Jul; 14(14):4469-74. PubMed ID: 18628461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry.
    Edgar RH; Tarhini A; Sander C; Sanders ME; Cook JL; Viator JA
    Lasers Surg Med; 2021 Apr; 53(4):578-586. PubMed ID: 32557708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance.
    Rapanotti MC; Cugini E; Campione E; Di Raimondo C; Costanza G; Rossi P; Ferlosio A; Bernardini S; Orlandi A; De Luca A; Bianchi L
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.
    Mumford BS; Robertson GP
    Mol Diagn Ther; 2014 Apr; 18(2):175-83. PubMed ID: 24297151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced detection of BRAF-mutants by pre-PCR cleavage of wild-type sequences revealed circulating melanoma cells heterogeneity.
    Fusi A; Berdel R; Havemann S; Nonnenmacher A; Keilholz U
    Eur J Cancer; 2011 Sep; 47(13):1971-6. PubMed ID: 21570823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
    Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
    J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.
    Pucciarelli D; Lengger N; Takacova M; Csaderova L; Bartosova M; Breiteneder H; Pastorekova S; Hafner C
    Int J Oncol; 2015 Jul; 47(1):81-90. PubMed ID: 25997619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and isolation of circulating melanoma cells using photoacoustic flowmetry.
    O'Brien CM; Rood K; Sengupta S; Gupta SK; DeSouza T; Cook A; Viator JA
    J Vis Exp; 2011 Nov; (57):e3559. PubMed ID: 22143421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
    Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
    Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases.
    Curry BJ; Myers K; Hersey P
    J Clin Oncol; 1999 Aug; 17(8):2562-71. PubMed ID: 10561323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.
    Palmieri G; Satriano SM; Budroni M; Cossu A; Tanda F; Canzanella S; Caracò C; Simeone E; Daponte A; Mozzillo N; Comella G; Castello G; Ascierto PA
    BMC Cancer; 2006 Nov; 6():266. PubMed ID: 17107608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.